Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens

Prostate

Volumn 57, Issue 2, 2003, Pages 160-164

  Jin, Chengliu ^a   McKeehan, Kerstin ^a   Wang, Fen ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

FGFR; Probasin; Prostate cancer; Prostate specific gene targeting

Indexed keywords

ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; CRE RECOMBINASE; DNA FRAGMENT; FIBROBLAST GROWTH FACTOR RECEPTOR; GLOBIN; MESSENGER RNA; PROBASIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; IMMUNOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; SEMINAL VESICLE; TRANSGENIC MOUSE; VAS DEFERENS;

ANIMALS; CHICKENS; GENE DELETION; GENE EXPRESSION; HUMANS; INTEGRASES; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); PROSTATE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; SEMINAL VESICLES; TISSUE DISTRIBUTION; VAS DEFERENS; VIRAL PROTEINS;

EID: 0141564629     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10283     Document Type: Article

References (22)

1. Wu X, Wu J, Huang J, Powell WC, Zhang J, Matusik RJ, Sangiorgi FO, Maxson RE, Sucov HM, Roy-Burman P. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 2001;101:61-69.
2. Maddison LA, Nahm H, DeMayo F, Greenberg NM. Prostate specific expression of Cre recombinase in transgenic mice. Genesis 2000;26:154-156.
3. Zhang J, Thomas TZ, Kasper S, Matusik RJ. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 2000;141:4698-4710.
4. Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, Yoshida T, Ferry G, Tucker G, Poupon MF, Chopin D, Thiery JP, Radvanyi F. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene 1999;18:7234-7243.
5. Naimi B, Latil A, Fournier G, Mangin P, Cussenot O, Berthon P. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate. Prostate 2002;52:245-252.
6. Feng S, Wang F, Matsubara A, Kan M, McKeehan WL. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 1997;57:5369-5378.
7. Matsubara A, Kan M, Feng S, McKeehan WL. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res 1998;58:1509-1514.
8. Wang F, McKeehan K, Yu C, McKeehan WL. Fibroblast growth factor receptor 1 phosphotyrosine 766: Molecular target for prevention of progression of prostate tumors to malignancy. Cancer Res 2002;62:1898-1903.
9. Suzuki K, Tokue A, Kamiakito T, Kuriki K, Saito K, Tanaka A. Predominant expression of fibroblast growth factor (FGF) 8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative components of testicular germ cell tumors. Virchows Arch 2001;439:616-621.
10. Simon R, Richter J, Wagner U, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res 2001;61:4514-4519.
11. Demiroglu A, Steer EJ, Heath C, Taylor K, Bentley M, Allen SL, Koduru P, Brody JP, Hawson G, Rodwell R, Doody ML, Carnicero F, Reiter A, Goldman JM, Melo JV, Cross NC. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: Transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001;98:3778-3783.
12. Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, Yoshida T, Ferry G, Tucker G, Poupon MF, Chopin D, Thiery JP, Radvanyi F. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene 1999;18:7234-7243.
13. Xerri L, Battyani Z, Grob JJ, Parc P, Hassoun J, Bonerandi JJ, Birnbaum D. Expression of FGF1 and FGFR1 in human melanoma tissues. Melanoma Res 1996;6:223-230.
14. Xu X, Weinstein M, Li C, Naski M, Cohen RI, Ornitz DM, Leder P, Deng C. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 1998;125:753-765.
15. Colvin JS, White AC, Pratt SJ, Ornitz DM. Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 2001;128:2095-2106.
16. Lewandoski M, Sun X, Martin GR. Fgf8 signalling from the AER is essential for normal limb development. Nat Genet 2000;26: 460-463.
17. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995;92:3439-3443.
18. Chung JH, Whiteley M, Felsenfeld G. A 5' element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 1993; 74:505-514.
19. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, Nagy A. Z/AP, a double reporter for cre-mediated recombination. Dev Biol 1999;208:281-292.
20. Wu X, Jin C, Wang F, Yu C, Chan WK, McKeehan WL. Stromal cell heterogeneity in FGF-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. Cancer Res 2002 (in press).
21. Jin C, Wang F, Wu X, Yu C, Luo Y, McKeehan WL. FGF9 and FGFR3 from a potential paracrine communication system from Epithelium to Stroma in rat prostate. J Biol Chem 2003 (in revision).
22. Wang F, McKeehan K, Yu C, Ittmann M, McKeehan WL. Targeting type 1 fibroblast growth factor receptor tyrosine kinase to prostate Epithelium induce prostatic intraepithelial neoplasia. The Prostate 2002 (in press).